Broadcasting the latest developments in GU cancer
Episode 197: The Uromigos Nashville 2022
Here are the details for the Livestream portions of The Uromigos Nashville meeting!
Bladder Cancel Panel on September 30, 1-2PM CST https://youtu.be/yzYkYZbCguE
Prostate Cancer on October 1, 10-11AM CST https://youtu.be/WghMP5kcqxQ
RCC Panel on October 1, 2-3PM CST https://youtu.be/4-DQ6lghQ2o
Episode 196: The COSMIC-313 Trial cabo/ipi/nivo in 1st line renal cancer
Toni Choueiri describes the study.
Episode 195 ESMO 2022: EV Pembrolizumab in 1st line bladder cancer
Peter O'Donnell describes the study.
Episode 194 ESMO 2022: Pegylated il-2 + nivolumab in renal cancer
Nizar Tannir describes this randomised phase 3 study presented at ESMO.
Episode 193 ESMO 2022: PRESTO - a phase III trial of androgen annihilation in biochemically relapsed prostate cancer
Rahul Aggarwal describes the results of this randomised phase III study.
Episode 192 ESMO 2022: Summary of ESMO Adjuvant RCC Trials
Axel Bex summarises the ipi/nivo, pembro and atezo studies.
This is a fantastic podcast! Great insight with provocative discussions (while keeping it lighthearted at the same time).... Thank you guys. Keep them coming....
Thoughtful discussion of data
Thank you for the thoughtful and humorous discussion of recent publications. Keep it going!!
This is a great series with insightful analysis of the data from recent clinical trials.